Neural Pressure Support, Synchrony and Respiratory Muscle Unloading
NPS
Neural Pressure Support, a Randomized Crossover Trial
1 other identifier
interventional
22
1 country
1
Brief Summary
In this study patients who are intubated and on ventilator for more than 24h will be ventilated at three different level of support in Pressure Support and Neural Pressure Support to study patient-ventilator synchrony and muscle unloading.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 17, 2022
CompletedFirst Submitted
Initial submission to the registry
November 19, 2022
CompletedFirst Posted
Study publicly available on registry
January 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedSeptember 19, 2024
September 1, 2024
3.6 years
November 19, 2022
September 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Patient-ventilator asynchronies
quantification of asynchronies by the use of the Edi catheter
20 minutes ventilatory traces recording
Secondary Outcomes (1)
respiratory muscle unloading
20 minutes ventilatory traces recording
Study Arms (1)
Neural Pressure Support
EXPERIMENTALPatients will be ventilated in Pressure Support and Neural Pressure Support at 3 different levels of support in randomized order
Interventions
Nasogastric tube will be removed and replaced by a Esophageal catheter and Electrical Diaphragm activity catheter and mechanical ventilation in mode Neural Pressure Support
Eligibility Criteria
You may qualify if:
- Patients intubated for more than 24 hours in the weaning phase from the ventilator.
You may not qualify if:
- bleeding disorders (PK INR\>1,5 or APTT\>50s or platelet count \<50000/µL)
- unstable circulation (requiring high vasopressor dose, for example Noradrenalin \>0,2µg/kg/min)
- severe lung disease (PFI ≤ 13,3 kPa)
- fever\> 38,5°C
- pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska University Hospital
Solna, 17176, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Francesca Campoccia Jalde
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Central Study Contacts
Karolinska University Hospital
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Francesca Campoccia Jalde, MD, PhD
Study Record Dates
First Submitted
November 19, 2022
First Posted
January 4, 2023
Study Start
May 17, 2022
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share